Published online Jan 26, 2020. doi: 10.12998/wjcc.v8.i2.404
Peer-review started: November 14, 2019
First decision: December 12, 2019
Revised: December 18, 2019
Accepted: December 22, 2019
Article in press: December 22, 2019
Published online: January 26, 2020
Processing time: 62 Days and 18.4 Hours
Goodpasture syndrome (GS) is a rare disease, the morbidity of which is estimated to be 0.5-0.8 per million per year. Hemorrhage is the most serious complication in renal biopsy. Despite the fact that both GS and hemorrhage after renal biopsy are rare, it has not been reported that they are likely to occur in the same patient.
A 30-year-old man with diffuse pulmonary hemorrhage and rapid progressive renal function caused by anti-glomerular basement membrane disease presented atypical symptoms without hemoptysis, accompanied by life-threatening hypoxemia. Plasmapheresis was performed, and glucocorticoids and cyclophosphamide were administered. The patient started to show signs of improvement. Percutaneous renal biopsy is an appropriate diagnostic measure that is commonly safe, but this patient experienced hemorrhage after operation, thus necessitating embolization of the renal artery to stop the bleeding. The patient’s condition was improved, and the serum anti-glomerular basement membrane antibody level was 106 AU/mL (normal range: < 24 AU/mL) and slowly decreased. His discharge medications were oral daily prednisone (30 mg) and continued maintenance hemodialysis.
GS is a rare organ-specific autoimmune disease that is invariably ubiquitous in the lung and kidney areas. Renal biopsy is the appropriate procedure for the treatment of GS disease, although it is an invasive measure.
Core tip: Goodpasture syndrome was first identified by Dr. Ernest Goodpasture, who described it as an association between alveolar hemorrhage and glomerulonephritis. We report on a young male patient with life-threatening pulmonary hemorrhage without hemoptysis, accompanied by hemorrhage after renal biopsy. This case highlights the critical importance of prompt diagnosis and initiation of therapy. However, preventive measures, such as the addition of fresh plasma, should be considered to decrease the incidence of hemorrhage in similar situations, especially for dialysis patients.